Technavio’s global continuous subcutaneous insulin therapy devices (CSITD) market research report forecasts the market to grow at a CAGR of over 9% during the forecast period.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181211005562/en/
Technavio has released a new market research report on the global continuous subcutaneous insulin therapy devices market for the period 2019-2023. (Graphic: Business Wire)
The rise in strategic partnerships will be one of the major trends in the global continuous subcutaneous insulin therapy devices market during 2019-2023. The vendors have been entering into strategic partnerships for integration of available and emerging technologies into their products. For instance, Medtronic entered into a collaboration with BD in June 2015. Under this collaboration, Medtronic will utilize BD FlowSmart technology in the development of an infusion set for CSITD.
This report is available at a USD 1,000 discount for a limited time only: View market snapshot before purchasing
According to Technavio analysts, one of the key drivers for the global continuous subcutaneous insulin therapy devices market is the rise in awareness about diabetes:
Global continuous subcutaneous insulin therapy devices market: Rise in awareness about diabetes
The rise in the prevalence of diabetes has resulted in increasing awareness efforts by various organizations across the globe. For instance, IDF is a type of umbrella organization that has over 240 national diabetes associations that are spread across 168 countries and territories around the globe. It has been working for raising awareness about diabetes from 1950 with a mission to enhance awareness about diabetes care and prevention globally.
According to a senior research analyst at Technavio, “The CDC runs diabetes prevention programs for reducing new cases of diabetes in the US. For instance, the CDC's Division of Diabetes Translation funds state and local health departments for supporting programs and activities for preventing or delaying the onset of type 2 diabetes, and for enhancing the health of people diagnosed with diabetes.”
Global continuous subcutaneous insulin therapy devices market: Segmentation analysis
This global continuous subcutaneous insulin therapy devices market analysis report provides market segmentation by product (tethered and patch) and by region (the Americas, APAC, and EMEA). This report provides an in-depth analysis of the prominent factors influencing the market, including drivers, opportunities, trends, and industry-specific challenges.
Of the two major products, the tethered segment held the largest continuous subcutaneous insulin therapy devices market share in 2018, contributing to about 70% of the market. This product segment will dominate the global market throughout the forecast period.
The Americas held the largest share of the market in 2018, accounting for around 44% share. It was followed by EMEA and APAC respectively. The Americas is expected to dominate the market throughout the period 2019-2023.
Looking for more information on this market? Request a free sample report
Technavio’s sample reports are free of charge and contain multiple sections of the report such as the market size and forecast, drivers, challenges, trends, and more.
Some of the key topics covered in the report include:
Market Landscape
Market Sizing
Five Forces Analysis
Market Segmentation
Geographical Segmentation
Market Drivers
Market Challenges
Market Trends
Vendor Landscape
About Technavio
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
If you are interested in more information, please contact our media team at [email protected].
View source version on businesswire.com: https://www.businesswire.com/news/home/20181211005562/en/
Technavio Research
Jesse Maida
Media & Marketing Executive
US:
+1 844 364 1100
UK: +44 203 893 3200
www.technavio.com